Halogenated Nucleosides
4-Chloro-5-iodo-7-(2-deoxy-3,5-bis-O-(p-toluoyl)--D-ribofuranosyl)-7H-pyrrolo[2,3-d]pyrimidine
Quick view. We supply 4-Chloro-5-iodo-7-(2-deoxy-3,5-bis-O-(p-toluoyl)--D-ribofuranosyl)-7H-pyrrolo[2,3-d]pyrimidine as a halogenated nucleoside analog for modified nucleoside, antiviral/antimetabolite and oligonucleotide precursor research. A public CAS number is not assigned for this exact form. Catalog target purity: Specification on request.
Structure confirmation
This item requires structure confirmation before quotation. Send the target structure, CAS number, SMILES, InChI or drawing for our technical review.
Canonical name plus a structure drawing, SMILES, InChI or unambiguous CAS number.
Protecting groups, stereochemistry, salt or counterion, hydration and requested form.
Agreed identity and purity criteria are documented in the quotation, specification and lot-specific data package.
Product profile
4-Chloro-5-iodo-7-(2-deoxy-3,5-bis-O-(p-toluoyl)--D-ribofuranosyl)-7H-pyrrolo[2,3-d]pyrimidine is classified as nucleoside or protected nucleoside intermediate.
4-Chloro-5-iodo-7-(2-deoxy-3,5-bis-O-(p-toluoyl)--D-ribofuranosyl)-7H-pyrrolo[2,3-d]pyrimidine can serve as a starting material, protected intermediate or analytical comparator in nucleoside and nucleotide route development.
For 4-Chloro-5-iodo-7-(2-deoxy-3,5-bis-O-(p-toluoyl)--D-ribofuranosyl)-7H-pyrrolo[2,3-d]pyrimidine, confirm the current specification, storage conditions and downstream-method compatibility before routine use.
Names and search terms
Useful catalog search terms
- Nucleoside or protected nucleoside intermediate
- Halogenated Nucleosides
Release documentation
The current specification defines the analytical method and acceptance criteria; the released lot result is reported on the CoA.
Additional HPLC, MS or NMR documentation can be agreed during technical review where available.
Additional application examples
- Typical work includes protection/deprotection studies, phosphorylation or phosphitylation route scouting and impurity identification.
- The material can support medicinal-chemistry analog preparation and process-development feasibility studies.
Related products
2'-5-CF3-dU
Halogenated Nucleosides · CAS: 70-00-8
BX-HN-00026-Cl-purine-2'-deoxyriboside
Halogenated Nucleosides · CAS: 4594-45-0
BX-HN-00038-Cl-2'-dA
Halogenated Nucleosides · CAS: 85562-55-6
BX-HN-00042'-Chloro-2'-deoxycytidine
Halogenated Nucleosides · CAS: 10212-19-8
BX-HN-00055-bromo-2'-deoxycytidine
Halogenated Nucleosides · CAS: 1022-79-3
BX-HN-00065-Iodouridine
Halogenated Nucleosides · CAS: 1024-99-3
Frequently asked questions
Can the package size for 4-Chloro-5-iodo-7-(2-deoxy-3,5-bis-O-(p-toluoyl)--D-ribofuranosyl)-7H-pyrrolo[2,3-d]pyrimidine be customized?
Yes. Share the initial quantity, expected future scale, delivery timeline and packaging preference for review.
What information should be included in a quote request?
Quote catalog number BX-HN-0109, the intended research workflow, required quantity and any additional HPLC, MS or NMR documentation needed.
Product-family literature
The publications below provide peer-reviewed context for the Halogenated Nucleosides product family and its named chemistry.